Catalyst Funds Management’s Incannex Healthcare Limited Common Stock IXHL Stock Holding History

Catalyst Funds Management’s Portfolio IXHL Stock Details IXHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$100	–	798
2024 Q3	$100	Hold	2	–	–	﹤0.01%	1267
2024 Q2	$147	Hold	2	–	–	﹤0.01%	1137
2024 Q1	$180	Buy	+2	New	+$240	﹤0.01%	1081

Other funds holding IXHL

AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Catalyst Funds Management's IXHL Position: Q4 2024 in Review

Catalyst Funds Management sold out of Incannex Healthcare Limited Common Stock (IXHL) in Q4 2024, closing a stake of 2 shares — an estimated $100 sold.

Catalyst Funds Management first reported a position in IXHL in Q1 2024 and held it in 3 quarters. The position peaked at $180 in Q1 2024. 7 funds tracked by Wall St. Rank hold IXHL as of Q4 2024.

Catalyst Funds Management reported no remaining Incannex Healthcare Limited Common Stock position as of Q4 2024 after selling out during the quarter.
Catalyst Funds Management sold 2 Incannex Healthcare Limited Common Stock shares in Q4 2024, an estimated $100.
Catalyst Funds Management first reported a position in Incannex Healthcare Limited Common Stock in Q1 2024 and held it in 3 quarters.
Catalyst Funds Management's Incannex Healthcare Limited Common Stock position peaked at $180 in Q1 2024.
7 funds tracked by Wall St. Rank held Incannex Healthcare Limited Common Stock as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.